Search Within

Craig Moskowitz

Formats
  1. Meeting Abstract (229)
  2. Journal Article (174)
  3. Book Section (3)
  4. Research Letter (1)
Groups
  1. Department of Medicine (407)
  2. Hematologic Malignancies, Division of (407)
  3. Center for Hematologic Malignancies (288)
  4. Lymphoma (273)
  5. Survivorship Research (176)
  6. Epidemiology and Biostatistics (103)

More Groups

People
  1. Andrew Zelenetz (207)
  2. David Straus (117)
  3. Paul Hamlin (113)
  4. Carol Portlock (106)
  5. Ariela Noy (94)
  6. Matthew Matasar (91)

More People

Years
  1. 2024 (1)
  2. 2023 (2)
  3. 2022 (3)
  4. 2021 (4)
  5. 2020 (6)
  6. 2019 (8)

More Years

Publications
  1. Blood (160)
  2. Journal of Clinical Oncology (46)
  3. Biology of Blood and Marrow Transplantation (23)
  4. Annals of Oncology (17)
  5. British Journal of Haematology (17)
  6. Haematologica (16)

More Publications

Publishers
  1. American Society of Hematology (165)
  2. American Society of Clinical Oncology (46)
  3. Elsevier Inc. (44)
  4. Oxford University Press (20)
  5. John Wiley & Sons (18)
  6. Ferrata Storti Foundation (16)

More Publishers

Results (407)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Interim results from a Phase 1/2 study of brentuximab vedotin in combination with nivolumab in patients with relapsed or refractory Hodgkin lymphoma
    Meeting Abstract

    Herrera, A. F.; Moskowitz, A. J.; Bartlett, N. L.; Vose, J. M.; Ramchandren, R.; Feldman, T. A.; Lacasce, A. S.; Ansell, S. M.; Moskowitz, C. H.; Fenton, K.; more...
    Hematological Oncology (2017)

    Fulltext@MSK | Save
  • Pembrolizumab monotherapy in patients with primary refractory classical Hodgkin lymphoma: Subgroup analysis of the Phase 2 KEYNOTE-087 study
    Meeting Abstract

    Zinzani, P. L.; Fanale, M. A.; Chen, R.; Armand, P.; Johnson, N.; Brice, P.; Radford, J.; Ribrag, V.; Molin, D.; Vassilakopoulos, T. P.; more...
    Hematological Oncology (2017)

    Fulltext@MSK | Save
  • Baseline metabolic tumor volume is an independent prognostic factor for relapsed and refractory Hodgkin lymphoma patients receiving PET-adapted salvage therapy with brentuximab vedotin and augmented ICE
    Meeting Abstract

    Moskowitz, A. J.; Schöder, H.; Gavane, S.; Thoren, K. L.; Fleisher, M.; Yahalom, J.; McCall, S. J.; Fox, S. Y.; Gerecitano, J.; Grewal, R.; more...
    Hematological Oncology (2017)

    Fulltext@MSK | Save
  • Phase I/IB dose escalation and expansion of ibrutinib and buparlisib in relapsed/refractory diffuse large B-cell lymphoma, mantle cell lymphoma, and follicular lymphoma
    Meeting Abstract

    Batlevi, C.; Hamlin, P.; Matasar, M.; Gerecitano, J.; Drullinsky, P.; Hamilton, A.; Straus, D.; Horwitz, S.; Kumar, A.; Moskowitz, C.; more...
    Hematological Oncology (2017)

    Fulltext@MSK | Save
  • Phase II study of idelalisib, a selective inhibitor of PI3Kδ, for relapsed/refractory classical Hodgkin lymphoma
    Journal Article

    Gopal, A. K.; Fanale, M. A.; Moskowitz, C. H.; Shustov, A. R.; Mitra, S.; Ye, W.; Younes, A.; Moskowitz, A. J.
    Annals of Oncology (2017)

    Fulltext@MSK | Save
  • Hodgkin lymphoma version 1.2017, NCCN Clinical Practice Guidelines in Oncology
    Journal Article

    Hoppe, R. T.; Advani, R. H.; Ai, W. Z.; Ambinder, R. F.; Aoun, P.; Bello, C. M.; Benitez, C. M.; Bernat, K.; Bierman, P. J.; Blum, K. A.; more...
    Journal of the National Comprehensive Cancer Network (2017)

    Fulltext@MSK | Save
  • Outcomes of diffuse large B-cell lymphoma patients relapsing after autologous stem cell transplantation: An analysis of patients included in the CORAL study
    Journal Article

    Van den Neste, E.; Schmitz, N.; Mounier, N.; Gill, D.; Linch, D.; Trneny, M.; Bouadballah, R.; Radford, J.; Bargetzi, M.; Ribrag, V.; more...
    Bone Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Accelerated total lymphoid irradiation-containing salvage regimen for patients with refractory and relapsed Hodgkin lymphoma: 20 years of experience
    Journal Article

    Rimner, A.; Lovie, S.; Hsu, M.; Chelius, M.; Zhang, Z.; Chau, K.; Moskowitz, A. J.; Matasar, M.; Moskowitz, C. H.; Yahalom, J.
    International Journal of Radiation Oncology, Biology, Physics (2017)

    Fulltext@MSK | Save
  • Outcomes of primary refractory diffuse large B-cell lymphoma (DLBCL) treated with salvage chemotherapy and intention to transplant in the rituximab era
    Journal Article

    Vardhana, S. A.; Sauter, C. S.; Matasar, M. J.; Zelenetz, A. D.; Galasso, N.; Woo, K. M.; Zhang, Z.; Moskowitz, C. H.
    British Journal of Haematology (2017)

    Fulltext@MSK | Save
  • A comprehensive assessment of toxicities in patients with central nervous system lymphoma undergoing autologous stem cell transplantation using thiotepa, busulfan, and cyclophosphamide conditioning
    Journal Article

    Scordo, M.; Bhatt, V.; Hsu, M.; Omuro, A. M.; Matasar, M. J.; DeAngelis, L. M.; Dahi, P. B.; Moskowitz, C. H.; Giralt, S. A.; Sauter, C. S.
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save